Commerzbank Aktiengesellschaft FI increased its holdings in shares of Colgate-Palmolive (NYSE:CL) by 10.1% during the fourth quarter, HoldingsChannel.com reports. The fund owned 151,528 shares of the company’s stock after purchasing an additional 13,907 shares during the quarter. Commerzbank Aktiengesellschaft FI’s holdings in Colgate-Palmolive were worth $11,433,000 as of its most recent filing with the SEC.

A number of other large investors have also added to or reduced their stakes in the stock. Jacobi Capital Management LLC increased its holdings in Colgate-Palmolive by 125.5% in the 3rd quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock valued at $104,000 after buying an additional 803 shares during the period. Krilogy Financial LLC increased its holdings in Colgate-Palmolive by 23.0% in the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock valued at $115,000 after buying an additional 289 shares during the period. Captrust Financial Advisors bought a new position in Colgate-Palmolive in the 2nd quarter valued at about $122,000. AlphaMark Advisors LLC increased its holdings in Colgate-Palmolive by 1.5% in the 2nd quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock valued at $126,000 after buying an additional 25 shares during the period. Finally, Bruderman Asset Management LLC bought a new position in Colgate-Palmolive in the 2nd quarter valued at about $126,000. 72.96% of the stock is currently owned by institutional investors and hedge funds.

Shares of Colgate-Palmolive (NYSE CL) opened at $72.43 on Friday. Colgate-Palmolive has a one year low of $65.45 and a one year high of $77.91. The company has a quick ratio of 0.34, a current ratio of 0.47 and a debt-to-equity ratio of 24.42. The firm has a market cap of $63,600.00, a P/E ratio of 31.77, a PEG ratio of 2.75 and a beta of 0.75.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 26th. The company reported $0.75 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.75. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The company had revenue of $3.89 billion for the quarter, compared to the consensus estimate of $3.92 billion. During the same period last year, the company posted $0.75 EPS. The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. sell-side analysts anticipate that Colgate-Palmolive will post 3.18 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, February 15th. Stockholders of record on Tuesday, January 23rd will be paid a $0.40 dividend. The ex-dividend date is Monday, January 22nd. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.21%. Colgate-Palmolive’s payout ratio is currently 70.18%.

In other news, insider Victoria L. Dolan sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, November 9th. The shares were sold at an average price of $73.07, for a total value of $730,700.00. Following the sale, the insider now directly owns 60,528 shares in the company, valued at approximately $4,422,780.96. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Justin Skala sold 126,393 shares of the firm’s stock in a transaction that occurred on Thursday, November 9th. The shares were sold at an average price of $72.97, for a total transaction of $9,222,897.21. Following the completion of the sale, the chief operating officer now owns 262,361 shares in the company, valued at $19,144,482.17. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 312,930 shares of company stock worth $22,902,679. 1.02% of the stock is currently owned by corporate insiders.

Several equities analysts have commented on CL shares. Royal Bank of Canada reissued a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive in a report on Sunday, October 8th. SunTrust Banks raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and raised their target price for the company from $65.00 to $85.00 in a report on Wednesday, October 11th. KeyCorp reissued a “hold” rating on shares of Colgate-Palmolive in a report on Monday, October 16th. Zacks Investment Research lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Tuesday, October 17th. Finally, Stifel Nicolaus set a $73.00 target price on shares of Colgate-Palmolive and gave the company a “hold” rating in a report on Sunday, October 29th. Three analysts have rated the stock with a sell rating, twelve have issued a hold rating and five have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $77.48.

TRADEMARK VIOLATION NOTICE: This article was first reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international copyright law. The legal version of this article can be read at https://theolympiareport.com/2018/02/03/commerzbank-aktiengesellschaft-fi-acquires-13907-shares-of-colgate-palmolive-cl.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.